Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07256015
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
The purpose of this study is to characterize the real-life experience of patients with moderate/severe psoriasis receiving deucravacitinib treatment, in terms of efficacy, safety, and health-related quality of life (HRQoL) in Italy
Official title: "DEMOS" - Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-08-05
Completion Date
2027-08-05
Last Updated
2025-12-01
Healthy Volunteers
No
Conditions
Interventions
DRUG
Deucravacitinib
According to the product label
Locations (1)
Azienda Ospedaliera Universitaria Integrata Di Verona
Verona, Verona, Italy